U.S. Antidepressant Medications Market

Published by: Frost & Sullivan

Published: Mar. 1, 2001

Table of Contents

• Introducing the Market Engineering Consulting Report
  
  
  
  • Overview
    
  
  
• Executive Summary
  
  
  
  • Introduction to the U.S. Antidepressant Market
    
  • Analysis of Market Engineering Research
    
  
  
• Market Engineering Research Methodology
  
  
  
  • Research Scope
    
  • Research Methodology
    
  • Market Engineering Forecasting Methodology
    
  • Glossary of Terms
    
  
  
• Industry Challenges
  
  
  
  • Identification of Challenges Facing the U.S. Antidepressant Market
    
  
  
• Market Engineering Research for the Total U.S. Antidepressants Medications Market 1996-2006
  
  
  
  • Market Overview
    
  • Market Restraints
    
  • Market Engineering Revenue Forecasts (1996-2006)
    
  • Competitive Analysis
    
  • Product Analysis
    
  
  
• Market Engineering Research for the U.S. Atypical Antidepressant Medications Market 1996-2006
  
  
  
  • Total Market Segment Analysis
    
  
  
• Market Engineering Research for the U.S. Selective Serotonin Reuptake Inhibitor Medications Market 1996-2006
  
  
  
  • Total Market Segment Analysis
    
  
  
• Market Engineering Strategy
  
  
  
  • What Is Market Engineering Strategy?
    
  • Market Engineering Strategic Recommendations
    
  
  
• Market Engineering Planning
  
  
  
  • Integrating Market Engineering into the Business Planning Process
    
  
  
• Implementation of Market Engineering
  
  
  
  • How to Implement Market Engineering in a Company
    
  
  
• Market Engineering Monitoring of the U.S. Antidepressant Market
  
  
  
  • Purpose of Market Engineering Monitoring
    
  
  
• Market Engineering Awards for the U.S. Antidepressant Market
  
  
  
  • Frost & Sullivan's 2001 Market Engineering Awards
    
  • Market Engineering Awards
    
  
  
• Database of Key Industry Participants
  
  
  
  • Distributors
    
  
  
• Market Engineering Supplement
  
  
  
  • Introduction
    
  • Strategic Significance of the Market Engineering Measurements
    
  • How to Improve the Market Engineering Strategy Development Process
    
  • How to Implement Market Engineering in a Company
    
  • How to Make the Most of This Market Engineering Report
    
  • How to Design a Successful Monitoring Program
    
  • Top Ten Critical Elements of a Market Engineering Program
    
  • Strategic Recommendations for Further Research
    
  
  

Abstract

The world's leading antidepressant medication manufacturer faces the expiration of its patent protection in late 2001, opening the way for generic products. This and other patent status changes will impact the U.S. antidepressant medications industry as a host of generic drug manufacturers will have new opportunities to gain market share. The rapid emergence of the generic medications segment, combined with a changing perception of depression as an illness, will fuel strong growth in the antidepressant medication industry. The strategic insights provided by this Frost & Sullivan research analyzes the selective serotonin reuptake inhibitors (SSRIs) and atypical antidepressant segments of the U.S. antidepressant medications market. It evaluates revenue and market trends, and provides a detailed forecast for the future. Market drivers and restraints for each segment are projected, making it an excellent resource for companies to increase their market presence.

Minimizing Side-Effects Key to Gaining Market Share

The ability to treat depression with minimal or no side effects remains a major challenge for drug developers. Some of the older medications posed life-threatening risks. Newer generation drugs lessened potential problems, but companies should continue to research and develop new medications that alleviate associated effects to increase market share. "Atypical antidepressants, the latest market entrants, have addressed some of the side-effect concerns communicated by patients," states the author of this report. "However, there is room for improvement."

Direct-to-Market Campaigns Increase Sales

Many market participants have little experience in product promotion; companies that best brand and market their drugs with differentiation will become front runners. Direct-to-consumer (DTC) campaigns are some of the most successful ways to educate end-users.

"DTC advertising is in its relative infancy in the U.S. markets, since its approval in 1997," states the author. "Pharmaceutical companies, with little to no consumer promotion experience, are just now beginning to implement effective advertising campaigns that target potential patients directly." This Frost & Sullivan research offers the most extensive market information available, enabling you to expertly meet end-users needs and design strategic plans to enhance your company's bottom line.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.